amiodarone has been researched along with Esophageal Neoplasms in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to examine the effects of amiodarone in restoring sinus rhythm in patients with new-onset atrial fibrillation during thoracic operations." | 7.91 | Transient new-onset atrial fibrillation during general thoracic operations and its treatment with amiodarone: a retrospective analysis in a single centre. ( Chen, M; Ji, C; Wu, D; Wu, J; Xu, M, 2019) |
| "This study aims to examine the effects of amiodarone in restoring sinus rhythm in patients with new-onset atrial fibrillation during thoracic operations." | 3.91 | Transient new-onset atrial fibrillation during general thoracic operations and its treatment with amiodarone: a retrospective analysis in a single centre. ( Chen, M; Ji, C; Wu, D; Wu, J; Xu, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, D | 1 |
| Wu, J | 1 |
| Chen, M | 1 |
| Ji, C | 1 |
| Xu, M | 1 |
1 other study available for amiodarone and Esophageal Neoplasms
| Article | Year |
|---|---|
Transient new-onset atrial fibrillation during general thoracic operations and its treatment with amiodarone: a retrospective analysis in a single centre.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Esophageal Neoplasms; Female; Humans; Intra | 2019 |